Latest revenue
$23.2K
as of 2026-03-31
Latest net income
$-2.2M
as of 2026-03-31
Net margin
-9298.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $5.3M
- Enterprise value
- $5.3M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $2.04
- 52-wk low
- $0.16
- Beta
- —
- Shares out
- 25.5M
5-year trend
What this company does
BUSINESS. (a) Business Development As used in this Annual Report on Form 10-K, or the Annual Report, references to the “Company”, “we”, “us”, or “our” refer to BioRestorative Therapies, Inc. We were incorporated in Nevada on June 13, 1997. On August 15, 2011, we changed our name from “Stem Cell Assurance, Inc.” to “BioRestorative Therapies, Inc.” Effective January 1, 2015, we reincorporated in Delaware. Effective December 31, 2022, we reincorporated in Nevada. We develop therapeutic products using cell and tissue protocols, primarily involving adult stem cells. We are currently pursuing our Disc/Spine Program with our initial investigational therapeutic product being called BRTX-100. In…
AI summary unavailable — showing raw filing excerpt
Generated from BRTX's filing dated 2026-03-26
Key risks
RISK FACTORS. The risk factors listed in this section provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. Readers should be aware that the occurrence of any of the events described in these risk factors could have a material adverse effect on our business, results of operations and financial condition. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. Preceding the full risk factors is a list of certain of the risk factors that follow. Reference is made to the…
AI summary unavailable — showing raw filing excerpt
Generated from BRTX's filing dated 2026-03-26
Profitability
Gross margin
93.4%
0.4%Operating margin
-4350.1%
51.0%Net margin
-3959.4%
76.8%Return on equity
-3992.2%
3693.0%Return on assets
-349.1%
377.4%Leverage
Debt / equity
10.44×
2275.2%Long-term debt / equity
0.01×
Debt / assets
91.3%
199.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $23.2K | -7.3% | $-2.2M | +59.7% | -9298.3% |
Q4 2025 2025-12-31 | $19.6K | -54.7% | $-3.2M | -96.0% | -16365.5% |
Q3 2025 2025-09-30 | $11.8K | -94.9% | $-3.0M | -178.4% | -25748.1% |
Q2 2025 2025-06-30 | $303.3K | +240.4% | $-2.7M | +34.1% | -875.8% |
Q1 2025 2025-03-31 | $25.0K | -28.6% | $-5.3M | -140.2% | -21359.2% |
Q4 2024 2024-12-31 | $43.3K | — | $-1.6M | — | -3778.6% |
Q3 2024 2024-09-30 | $233.6K | +660.9% | $-1.1M | +62.7% | -467.2% |
Q2 2024 2024-06-30 | $89.1K | +38.1% | $-4.0M | -35.2% | -4521.4% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Misc Health & Allied Services, NEC · SIC 8090
Your notes
Keep private notes on BRTX — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns BRTX
Institutional value
$37.9K
Total shares held
139.5K
Distinct holders
8
-7 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 99.8K | $27.2K | — | New |
| 2 | VANGUARD FIDUCIARY TRUST CO | 39.5K | $10.7K | — | New |
| 3 | SBI Securities Co., Ltd. | 199 | $54 | +80 (+67.2%) | Added |
| 4 | Rossby Financial, LCC | 11 | $3 | +0 (+0.0%) | No change |
| 5 | Cornerstone Planning Group LLC | 11 | $3 | +10 (+1000.0%) | Added |
| 6 | TD Waterhouse Canada Inc. | 3 | $1 | +0 (+0.0%) | No change |
| 7 | Caitong International Asset Management Co., Ltd | 1 | $0 | — | New |
| 8 | Parallel Advisors, LLC | 1 | $0 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once BRTX's latest filing finishes processing.